in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/fine chemicals roundup—6 December
December 6, 2012 | Deepti Ramesh
Cambrex appoints former Teva CEO as board vice chairman Cambrex (East Rutherford, NJ) says it has appointed Shlomo Yanai to its board of directors and will serve as its nonexecutive vice chairman. Yanai had been the president and CEO of Teva Pharmaceutical (Petaḥ Tiqwa, Israel)—the largest generic pharmaceutical manufacturer in the world—until his retirement in mid-2012. As vice chairman of the Cambrex board, he will work closely with the company's other directors and its leadership team to formulate and help execute Cambrex's growth...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee